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Physiological function and pathology of the Alzheimer’s disease causing amyloid
precursor protein (APP) are correlated with its cytosolic adaptor Fe65 encompassing
a WW and two phosphotyrosine-binding domains (PTBs). The C-terminal Fe65-PTB2
binds a large portion of the APP intracellular domain (AICD) including the GYENPTY
internalization sequence fingerprint. AICD binding to Fe65-PTB2 opens an intra-
molecular interaction causing a structural change and altering Fe65 activity. Here we
show that in the absence of the AICD, Fe65-PTB2 forms a homodimer in solution and
determine its crystal structure at 2.6 Å resolution. Dimerization involves the unwinding
of a C-terminal α-helix that mimics binding of the AICD internalization sequence, thus
shielding the hydrophobic binding pocket. Specific dimer formation is validated by
nuclear magnetic resonance (NMR) techniques and cell-based analyses reveal that
Fe65-PTB2 together with the WW domain are necessary and sufficient for dimerization.
Together, our data demonstrate that Fe65 dimerizes via its APP interaction site,
suggesting that besides intra- also intermolecular interactions between Fe65 molecules
contribute to homeostatic regulation of APP mediated signaling.
Keywords: Fe65, phosphotyrosine-binding domain (PTB), homodimerization, amyloid precursor protein (APP),
AICD, Alzheimer’s disease
INTRODUCTION
The Fe65s (Fe65, Fe65L1 and Fe65L2) are a family of conserved eukaryotic adaptor proteins
involved in a variety of biological processes (Russo et al., 1998; McLoughlin and Miller, 2008;
Minopoli et al., 2012). Special attention has been given to the brain-enriched Fe65 as its expression
pattern parallels the amyloid precursor protein (APP; Guenette et al., 2006). Accordingly, the
physiological functions of the two proteins are interdependent and knockout studies resulted in
markedly similar phenotypes (Zambrano et al., 2002; Guenette et al., 2006; Strecker et al., 2016).
APP is a single-spanning type-1 transmembrane protein (Coburger et al., 2014) with numerous
neuronal functions especially in the developing brain (Müller and Zheng, 2012). Sequential
regulated proteolysis of APP by different secretases (Lichtenthaler et al., 2011; Haass et al., 2012)
results in multiple break-down products including soluble ectodomains, the Aβ-peptides forming
the amyloids in Alzheimer’s disease, and the APP intracellular domain (AICD) that is released into
the cytosol (Selkoe and Hardy, 2016). The AICD is an intrinsically disordered peptide of 47 residues
(Ramelot et al., 2000) and includes the GYENPTY internalization sequence that besides Fe65 binds
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also to many other adaptor proteins (Russo et al., 1998) with a
variety of physiological functions and pathological implications
(Müller et al., 2008; Pardossi-Piquard and Checler, 2012).
Fe65 determines localization and nuclear signaling of APP
and modulates APP processing and Aβ-peptide generation
(McLoughlin and Miller, 2008). Fe65 is a multidomain protein
including an N-terminal α-helical domain and three protein-
protein interaction modules: a WW domain and two consecutive
C-terminal phosphotyrosine-binding (PTB) domains
(Figure 1A). The WW domain binds to the Mena protein
(Ermekova et al., 1997) involved in actin dynamics and cell
motility thus regulating neuronal positioning in the developing
brain. Fe65-PTB1 has been mainly implicated as central
module of a ternary AICD/Fe65/Tip60 complex responsible
for transcriptional activity of APP (Cao and Südhof, 2001),
with the histone acetyltransferase Tip60 being a key regulator
of genome expression and stability. Further data suggested
Fe65 to provide a dominant role for nuclear signaling (Yang
et al., 2006). The analysis of the AICD/Fe65/Tip60 interaction
revealed that only membrane-bound AICD in context of APP
and not on its own is a potent transactivator of transcription
(Cao and Südhof, 2004). The distinction had been interpreted
by a membrane association dependent transition of Fe65 from
a closed to an open and active conformation, involving its WW
and PTB2 domain.
Most attention has been given to Fe65-PTB2 as it directly
interacts with the AICD and thus functionally joins the two
proteins (Borg et al., 1996). The interaction is phosphotyrosine-
independent and untypically for PTB-interactions
(Uhlik et al., 2005) includes an extended interface of 28 AICD
residues including two α-helices (αN and αC; Figure 1B;
Radzimanowski et al., 2008c). The GYENPTY internalization
sequence is recognized in a rather hydrophobic crevice with
GYE involved in a PTB-typical β-augmentation manner and
NPTY starting helix αC and placing the canonical PTB-relevant
tyrosine in its binding pocket. Unique for the AICD/Fe65-
PTB2 complex is the N-terminal binding helix αN within
AICD that is capped by the T668PEE-motif. Phosphorylation of
threonine T668 regulates the interaction and has been identified
as sensitive checkpoint switching between physiological and
pathological APP related pathways (Ando et al., 2001).
Here we present structural and functional data on Fe65-PTB2
revealing the domain as flexible module forming a homodimer
in vitro and ex vivo in the absence of APP. Dimerization
mimics the AICD-interaction and at the same time shields
the hydrophobic crevice. The interaction competes with AICD
binding and therefore with APP signaling depending on its
cellular context.
MATERIALS AND METHODS
Protein Production and Characterization
for X-ray Structure Analysis
Human Fe65-PTB2 (residues 534-667; UniPROTKB:
APBB1_HUMAN, O00213) was expressed and purified for
crystallization as described previously (Radzimanowski et al.,
2008a). To avoid precipitation of concentrated and pure Fe65-
FIGURE 1 | Fe65 and amyloid precursor protein (APP). (A) Domain architecture of human Fe65 with numbering of domain boundaries. (B) Schematic for
Fe65-mediated APP-signaling by the APP intracellular domain (AICD)/Fe65-phosphotyrosine-binding domains 2 (PTB2) complex at the cell membrane. Structural
details for the interaction are depicted as follows: αN and αC: AICD helices; T and Y: AICD sequence fingerprints (T: T668PEE, Y: N684PTY) as part of AICD helices,
GYE: AICD region involved in β-augmentation with Fe65-PTB2. APP-cleavage sites by secretases are indicated by Greek symbols. (C) X-ray structure of the
Fe65-PTB2 dimer of dimers. The dimer is constituted by a “complementing” subunit (blue) with a transition of the C-terminus to strand βct (dark blue), while the
“accommodating” subunit (yellow) contains the entire helix α3 (orange). The second dimer symmetrically attached by β-augmentation is shown with gray subunits.
The central disulfide bond connecting the dimer of dimers is shown in magenta. (D) Close-up on the C-terminal Fe65-transition. According regions (L656-D663) of the
complementing (dark blue, βct) and accommodating (orange, α3) subunits are given with side chains and numbering.
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PTB2, 5% (v/v) glycerol was added in the final size exclusion
chromatography (SEC) buffer. Multi angle light scattering
(MALS) was performed in line with SEC and monitored by
refractive index measurements (Wyatt technology). The protein
(5–20 mg/mL) was crystallized within 3 days in an automated
platform at 18◦C by mixing equal amounts (200 nL) of protein
solution and a reservoir containing 1.6 M ammonium sulfate,
0.08 M sodium acetate pH 4.6 and 20% (v/v) glycerol in a
sitting drop setup. The high glycerol concentration allowed
direct flash-cooling in liquid nitrogen for X-ray structure
analysis. X-ray data collection was done at beamline ID29 of
the European Synchrotron Radiation Facility (ESRF). Data
was integrated with program XDS (Kabsch, 2010) and scaled
and merged with program AIMLESS (Evans and Murshudov,
2013) from the CCP4-package (Winn et al., 2011). The structure
was solved by the Molecular Replacement method (PHENIX
package; Adams et al., 2010) using a monomeric Fe65-PTB2
molecule taken out of the Fe65-PTB2/AICD complex (PDB
entry: 3dxc). Iterative model building, refinement and validation
were performed with programs COOT (Emsley et al., 2010) and
PHENIX. All structural figures were prepared using PyMOL
(Molecular Graphics System, Version 1.5.0.4 Schrödinger,
LLC)1.
NMR Measurements
Sequences for wildtype (wt) Fe65-PTB2 and the C633E mutant
were cloned into a pETHis vector using NcoI/BamHI restriction
enzymes. The proteins were expressed in E. coli BL21(DE3)
Rosetta pLysS grown in LB media or for 15N- or 13C/15N-
labeling in M9 media by induction with 0.5 mM IPTG overnight
at 22◦C. Pellets were lysed by sonication in 20 mM Tris pH
8.0, 150 mM NaCl, 0.2% (v/v) Nonidet P-50 and 2 mM DTT,
and the proteins purified by nickel affinity chromatography.
Spin-labeling of the C633E mutant was performed by incubation
with a five-fold molar excess of 3-(2-Iodoacetamido)-proxyl free
radical dissolved in methanol over night at 4◦C. Free spin-label
was removed by buffer exchange or SEC into 20 mM Na2HPO4
pH 6.5 and 150 mM NaCl. Nuclear magnetic resonance
(NMR) spectra were acquired on Bruker Avance III 600 and
800 spectrometers with a cryogenic triple resonance probe and
a Bruker Avance III 700 with a triple resonance probe at
concentrations of 0.1–0.5 mM in the same buffer at 300 K.
Data where processed with NMRPipe (Delaglio et al., 1995)
and analyzed using NMRView (Johnson and Blevins, 1994).
The transfer of backbone assignment from the wt protein (Dietl
et al., 2014) was confirmed by analyzing HNCA, HNCACB
and CBCA(CO)NH spectra of the C633E mutant. Chemical
shift based secondary structure predictions and structure based
chemical shift predictions where done using the programs
TALOS+ (Shen et al., 2009) and SPARTA+ (Shen and Bax,
2010). Model-free Liparai-Szabo parameters derived from the
15N relaxation data of the C633E mutant were analyzed and
compared to hydrodynamic diffusion tensors using the programs
ROTDIF and ELM (Berlin et al., 2013). Paramagnetic Relaxation
Enhancements where measured and analyzed as described
1http://www.pymol.org
(Simon et al., 2010). SAXS measurements were carried out at
the BM29 beamline at ESRF in Grenoble (Pernot et al., 2013).
Samples were measured in NMR buffer (20 mM Na2HPO4 pH
6.5, 150 mM NaCl, 2 mM DTT) at concentrations between
0.25 and 6 mg/mL, a temperature of 300 K and a wavelength of
1 Å. Data was processed using the ATSAS suite (Petoukhov et al.,
2012).
Pull-Down Experiments
The coding sequence for full-length human Fe65 was inserted
into the pUKBK vector system (Kohli et al., 2012) by
standard cloning techniques in order to attach either a
streptavidin-binding peptide (SBP) together with a myc-tag or
a mCherry (mChe)-tag to the protein N-terminus. Thereof, the
following deletion constructs were generated: ∆PTB2 (Fe65(1-
532)-(665-710)), ∆WW (Fe65(1-253)-(286-710)), and ∆WW-
∆PTB2 (Fe65(1-253)-(286-532)-(665-710)). After transfection
with Lipofectamine 2000 (ThermoFisher Scientific) for 22 h,
HEK293 cells were lysed in homogenization buffer consisting
of 140 mM KCl, 20 mM HEPES pH 7.2, 10 mM NaCl, 5%
(v/v) glycerol, 2 mM MgSO4, 1% (v/v) Triton-X100, 2 mM
DTT, EDTA-free Protease-Inhibitor Cocktail (Roche), and
2 mM Phenantrolen. Pull-down assays were performed with
Dynabeadsr M-280 Streptavidin (ThermoFisher Scientific) and
bound proteins were eluted with biotin and further separated
on NovexTM 10%–20% Tricine Protein Gels. Antibodies used
for detection were the c-myc antibody (1:1000, 9E10, Roche),
mCherry antibody (1:1000, 5F8, Chromotek), and GAPDH
antibody (1:5000, Meridian Life Science). ECL detection was
performed with the ImageQuant LAS 4000 (GE Healthcare
Life Sciences). Quantification was done on the latest exposure
before saturation of the brightest band on the blot, using the
ImageQuant TL software.
Co-Immunoprecipitation
Co-Immunoprecipitation (Co-IP) experiments were performed
as described before (Baumkotter et al., 2014). Briefly,
HEK293 cells were transfected with pcDNA3.1 constructs
containing FE65-HA, FE65-Flag or APP-myc using JetPRIME
(Polyplus transfection). Twenty to twenty-two hours after
transfection cells were harvested and lysed in 150 mM NaCl2,
50 mM Tris/HCl pH 7.5, 2 mM EDTA, 1% (v/v) NP40 and
freshly added Complete Protease Inhibitor mix (Roche) for
20 min on ice. After centrifugation at 16,000× g for 10 min the
supernatant was pre-cleared with protein A Sepharose beads (GE
Healthcare). Then the supernatant was incubated over night with
anti-HA agarose beads (Roche) to allow binding of HA-tagged
FE65. After washing bound proteins were eluted by denaturation
with SDS sample buffer at 95◦C. Samples were separated on 8%
Tris/glycine gels and probed via immunoblotting for HA-, Flag-
and myc-tagged constructs.
Subcellular Fractionation
Subcellular fractionation was performed according to Abcams
subcellular fractionation protocol. HEK293 cells were transfected
as described before. Twenty to twenty-two hours post
transfection cells were resuspended in 1 mL of fractionation
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 May 2017 | Volume 10 | Article 140
Feilen et al. Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
buffer (250 mM Sucrose, 20 mM HEPES, 10 mM KCl, 2 mM
MgCl2, 1 mM EDTA and 1 mM EGTA with freshly added
Complete Protease Inhibitor mix (Roche)) and passed 10 times
through a 27 gauge needle. After differential centrifugation
at 720× g and 10,000× g for 5 min and 100,000× g for
1 h the supernatant (cytosolic fraction) was transferred and
kept on ice for further analysis. The sediment (membrane
fraction) was resuspended by pipetting and pass through
10 times a 27-gauge needle. Protein concentration of membrane
and cytosolic fraction was determined using the BCA assay
(Sigma).
Blue Native Gel Electrophoresis
For Blue Native Gel analysis 100 µg protein of the
cytosolic and membrane fraction was diluted in 1.5 M
amino caproic acid, 0.05 M Bis-Tris, pH 7, 1.25% (w/v)
dodecyl maltosidase and 5% (w/v) Coomassie Brilliant Blue
G250, as described in detail before (Eggert et al., 2009).
Afterwards, samples were separated on a 4%–15% (w/v)
Tris-HCl gel (Biorad), transferred on a PVDF membrane
and probed via immunoblotting for HA- and myc-tagged
constructs.
RESULTS
Fe65-PTB2 Dimerization
Recombinantly expressed human Fe65-PTB2 (residues 534-
667) is difficult to purify as it precipitates at higher protein
concentrations in the mg/mL range. Instability is related to
the exposure of a hydrophobic crevice that corresponds to the
AICD binding site and complex formation dramatically enhances
solubility about a 100-fold (Radzimanowski et al., 2008c).
When purified via SEC, Fe65-PTB2 partitions in monomeric,
dimeric and tetrameric species as validated by multi-angle light
scattering (MALS) and on SDS-PAGE the protein appears as
detergent-resistant dimer (Supplementary Figure S1). Unspecific
aggregation of Fe65-PTB2 at concentrations in the mg/mL range
can be prevented by the addition of glycerol and we subsequently
crystallized the domain and solved its crystal structure by
molecular replacement at 2.6 Å resolution (Table 1).
Fe65-PTB2 crystallizes as dimer of dimers with a continuous
central β-sheet (Figure 1C). Dimerization occurs via a structural
transition of the C-terminal α-helix α3 within one Fe65-PTB2
subunit (the ‘‘complementing’’ subunit) in respect to the
conformation as seen in the previously solved AICD/Fe65-
PTB2 complex (rmsd of 0.85 Å for 123 Cα-atoms; Figure 1D,
Supplementary Figure S2; Radzimanowski et al., 2008c).
The last two helical turns dissolve (starting at L656) and
adopt an extended β-conformation that complements the
‘‘accommodating’’ subunit in trans (dimer interface: 585 Å2). The
interface is classified just about stable (Krissinel and Henrick,
2007). The newly formed β-strand (defined here as βct) quasi-
symmetrically mediates also the dimer of dimer contact with
the tetrameric assembly being stabilized by a disulfide bridge
between respective cysteine (C661) residues (Figure 1C).
TABLE 1 | Data collection and refinement statistics.
Data collection
Space group P 1 21 1
Cell dimensions
a, b, c (Å) 56.6 104.3 60.6
α, β, γ (◦) 90 112.0 90
Resolution (Å) 49.44–2.6 (2.74–2.6)
Rpim (%) 7.3 (39.5)
Wilson B-factor (Å2) 39.0
I/σ(I) 9.0 (2.3)
CC1/2 99.1 (83.5)
Completeness (%) 99.3 ( 98.3)
Redundancy 6.6 (6.2)
Wavelength (Å) 1.033
Refinement
No. reflections 19931 (1993)
Rwork (%) 19.3 (29.6)
Rfree (%)∗ 24.1 (40.6)
No. atoms 3970
protein 3832
ligand/ion 60
Protein residues 501
B-factors (Å2) 50.4
R.m.s. deviations
bond lengths (Å) 0.002
bond angles (◦) 0.60
Ramachandran plot
allowed (%) 99.8
∗for 5% of all data. Statistics for the highest-resolution shell are shown in
parentheses.
Fe65-PTB2 Dimer Structure in Solution
Having solved the crystal structure of Fe65-PTB2, we
had to make sure that the observed interactions did not
represent a crystallographic artifact and are also present
in solution. We therefore first performed concentration
dependent (0.25–6 mg/mL) small angle X-ray scattering (SAXS)
measurements under reducing conditions to avoid the covalent
and likely non-physiological cysteine bridge. The data showed
a sharp increase in intensity at very small scattering angles that
becomes more pronounced with higher concentrations and
thus confirming the observation of the presence of aggregation
(Figure 2A). Accordingly, the deducedmolecular masses showed
a strong concentration dependence that reflects the monomer-
dimer transition. Calculating the theoretical scattering curves
of the monomer, dimer and tetramer structures and fitting
them against the experimental data, revealed the best fit to
correspond to the crystallographic dimer (Supplementary Figure
S3A), which holds true for the whole concentration range and
also when the data are interpolated to zero concentration.
Calculations of monomer and dimer content based on fitting
linear combinations of two structures range from more than
20% of monomer to almost exclusively dimer at higher
concentrations, but should be taken as rough estimates with
the given data quality and the insecurity of especially the dimer
structural model. In accordance with these data, a dissociation
constant could be estimated by preliminary isothermal titration
calorimetry (ITC) measurements to be in the low micromolar
range (data not shown).
In order to obtain high resolution structural information
for Fe65-PTB2 dimerization in solution, we performed an
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FIGURE 2 | The Fe65-PTB2 dimer in solution. (A) Small angle scattering data measured at three different protein concentrations. The presence of self-aggregation
leads to a pronounced increase in scattering intensity at low angles. The radius of gyration extracted from the Guinier plot (inset) is slightly higher than expected for a
dimer and the initial intensity values almost reaches the expected value for the dimer. (B) Secondary structure predicted from backbone chemical shifts with positive
blue bars indicating β-sheets and negative red bars α-helices. The secondary structure of the accommodating subunit (long α3 helix) is shown below for comparison.
(C) Backbone order parameters S2 derived from 15N nuclear magnetic resonance (NMR) spin-relaxation data. The decrease of the order parameter for the
C-terminal residues indicates the unfolding of the α-helix in this region resulting in a rapid reorientation of the N-H bond vectors on a ns to ps timescale. (D) Residues
experiencing paramagnetic relaxation enhancements at the backbone NH when a nitroxide spin-label is attached to C661. The protein surface of the complementing
subunit is shown in color if the average intensity ratio of the observed 1H-15N peak in the paramagnetic and diamagnetic NMR spectra of the corresponding residue
and its two neighbors is smaller than 0.7 and thus identifies amino acids that are close to the paramagnetic center. Residues in yellow are bleached for molecules
that are simultaneously 15N and nitroxide labeled, while residues in red are also bleached when exclusively 15N and nitroxide labeled proteins are mixed. The
spin-label carrying C661 residues are highlighted for the monomer (on the C-terminal α-helix) and the crystallographic dimer (on the extra β-strand).
extended NMR characterization. Overall, we observe a high
consistency between the backbone chemical shift data and the
dihedral angles observed in the crystal structure (Figures 2B,
Supplementary Figure S3B). For the C-terminus, the chemical
shifts predict the existence of a helix until Y658 and indicate an
increase in backbone flexibility starting fromM655. Interestingly,
the observed secondary Cα-Cβ chemical shift differences for
the C-terminus are in between the values predicted for the
accommodating (long C-terminal α-helix) and complementing
(β-sheet augmentation) subunits of the crystal structure.
A more detailed picture for the internal dynamics and
dimerization was obtained by the analysis of 15N relaxation
data. The average ratio of transverse and longitudinal relaxation
rates measured at 300 K indicated a rotational correlation
time τc of 10.6 ns. This value compares to 8.9 ns (for
complementing subunit) and 15.7 ns (for crystallographic dimer)
as calculated from the coordinates. Assuming a rapid exchange
between rigid monomers and dimers the experimental value
would suggest a high percentage of monomers in solution.
However, since the intermolecular interaction is mediated by
the flexible C-terminus, we envision a dimer with a rather
flexible connection between the monomers and thus with faster
effective rotational correlation time than expected for a rigid
dimer. This model is supported by the observation of quickly
Frontiers in Molecular Neuroscience | www.frontiersin.org 5 May 2017 | Volume 10 | Article 140
Feilen et al. Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
reducing backbone order parameters S2 for the C-terminal
residues starting from Y658 (Figure 2C, Supplementary Figure
S3C).
To further characterize the oligomerization in solution, we
introduced nitroxide spin-labels covalently attached to cysteine
residues to measure paramagnetic relaxation enhancements
(PREs). The presence of the electron spin leads to signal
broadening of nuclear spins in spatial proximity (less than
∼20 Å) to the nitroxide and can assist NMR protein structure
determination. Due to the r−6 dependence of the induced
relaxation, the signal bleaching can also be used to structurally
and dynamically characterize specific encounter complexes
(Clore, 2015). Since Fe65-PTB2 contains six native cysteines and
the evaluation of the experiment requires a single spin-label
attached to eachmolecule, we performed an extensive mutational
analysis to determine the accessibility and structural importance
of all native cysteines. In the end, only two cysteines (C633 and
C661) were solvent exposed to be efficiently paramagnetically
labeled. Of particular interest are the PRE results for the
C633E mutant, which positions the spin-label solely on C661
at the C-terminus in the center of the oligomerization region.
We measured the intensity ratios in 15N-1H heteronuclear
correlation spectra (HSQC) between the paramagnetic and
diamagnetic state of the molecule (Supplementary Figures
S3D,E). Due to the instability and precipitation of the molecule
in solution during the measurements, a number of intensity
ratios larger than one for residues that are not in proximity
of the nitroxide were observed. Therefore, and because of the
difficulties to accurately model the spin-label being attached to
a flexible C-terminus, we resign from a detailed quantitative
analysis of the data. A qualitative picture however can be
obtained by plotting the experimental Ipara/Idia ratios onto the
X-ray structure. The lowest ratios are observed for residues in
the C-terminal helix and the loops and secondary structure
elements in the vicinity of the C-terminus. To disentangle
intra- and inter-molecular contributions, we performed a second
experiment with a mixed sample of 14N-paramagnetic and
15N-diamagnetic molecules. The observed PREs are exclusively
due to inter-molecular proximity of the radical. Bleaching was
observed for patches adjacent to the hydrophobic crevice and
on surface loops consistent with the presence of the dimer and
tetrameric species in solution (Figure 2D). Strongest bleaching
with Ipara/Idia ratios below 0.3 occurred for residues L609 and
F611 that also are in closest contact within the crystallographic
dimer and for C661 itself that also bridges the observed dimer of
dimers.
Taken all NMR measurements together, a transient dimer
formation as seen in the crystal structure is validated as
homotypic interaction in solution. The tetrameric and covalent
linkage of two dimers seems to be favored only under
high concentrations and oxidizing conditions as seen in the
crystallographic array.
Fe65-PTB2 Mimics the AICD
The central part within the AICD/Fe65-PTB2 interface has
been previously shown to be constituted by antiparallel
β-augmentation of the PTB domain with the G681YE sequence
FIGURE 3 | Fe65 mimicry of AICD binding. (A) Left: X-ray structure of the
AICD/Fe65-PTB2 complex (PDB: 3dxc; Radzimanowski et al., 2008c). The
central interacting part of the AICD is detailed: G681YE in dark blue, N684PTY
in cyan. Right: same view and coloring of the Fe65 dimer with the AICD
replaced by the accommodating subunit. The geometry and type of
interactions mimic the AICD/Fe65-PTB2 complex. Matching sequences are
given in the alignment. Coloring as in Figure 1D. (B) Surface potential
(±5 kBT/e; blue: positive, red: negative) of the Fe65-PTB2 dimer. Dimerization
results in an extended positively charged groove with tightly bound sulfate ions
originating from crystallization. (C) Coordination and electron densities
(2mFo-DFc, 1.0 σ) for the centrally bound sulfate ions (magenta). Binding
occurs next to strand βct and the N-terminus of Fe65-PTB2 (green). Same
orientation as in Panel B as indicated by the red rectangle.
fingerprint of the AICD (APP695 numbering; Figure 3A, left
panel; Radzimanowski et al., 2008c). The glycine presents an
essential hinge that places the N-terminally located helix αN of
the AICD almost perpendicular to the C-terminal helix α3 of
Fe65-PTB2 whereas the tyrosine residue (Y682) is imbedded
in a hydrophobic pocket formed by residues of helix α3.
Glutamate E683 is involved in an intramolecular salt bridge
with a lysine (K688) following the NPTY687 sequence. In the
crystal structure of the Fe65-PTB2 dimer, the induced strand βct
with the C661LD sequence directly matches to the AICD strand
(Figure 3A, right panel). Cysteine C661 occupies the glycine
position although due to the restrained main chain flexibility
it does not introduce a similar hinge. The hydrophobic leucine
L662 superposes with the tyrosine and aspartate D663 forms an
AICD-equivalent intramolecular salt-bridge with arginine R665.
Thus, the complementing Fe65-PTB2 mimics the interacting
AICD in space and charge. Of note, the accommodating
Fe65-PTB2 subunit does not show the structural transition.
The hydrophobic crevice of the complementing subunit is
therefore still available, however, the adjacent C-terminal
binding site for helix αC of the AICD is destroyed by the
helical unwinding and the respective space is occupied by
the accommodating subunit (Supplementary Figure S2C). In
summary, Fe65-PTB2 dimerization results in a structural change
that blocks the AICD binding site either fundamentally in
the accommodating subunit or partially in the complementing
subunit.
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A Basic Cluster Next to the Dimerization
Site
In order to evaluate changes of the surface properties due
to dimerization we calculated surface charge potentials. The
analysis revealed a pronounced positively charged patch (R605,
R607, R657, K660 and R665) in the center of the dimer
directly located at the transition site of the C-terminal helix
(Figures 3B,C). Due to its location, the shape of the patch
differs between an extended (complementing subunit with
extended strand βct) and a condensed form (accommodating
subunit with folded C-terminal helix; Supplementary Figure
S4). Fe65-PTB2 was crystallized in sulfate conditions and
we find sulfate ions bound to both the condensed and
extended patches. Most strikingly, in the elongated patch next
to the dimer interface we find three adjacent sulfate ions
(Figures 3B,C). The spatial arrangement of the ions perfectly
match to the three phosphoryl-groups of the head-group (IP3)
of phosphatidyl-inositol-4,5-bisphosphate (PIP2; Supplementary
Figure S4), which has been found earlier to bind to Fe65 by
liposome flotation assays (Cao and Südhof, 2004). PIP2-binding
is a recurrent and functionally important feature of many PTB
domains due to their juxtamembrane location and always occurs
in similar basic clusters (Uhlik et al., 2005). Of note, also the
N-terminus of Fe65-PTB2, and thus the PTB1-PTB2 linker
region implicated in the intramolecular closure by binding to the
WW-domain (Cao and Südhof, 2004), locates next to the basic
cluster.
Fe65 Dimerization In Vivo
All structural studies have been performed in vitro with isolated
Fe65-PTB2 at rather high protein concentrations and they do
not necessarily reflect the in vivo situation in context of the
full-length protein and the cellular environment. We therefore
set out to determine its relevance by testing Fe65 dimerization
in the cellular context. HEK293 cells expressing Fe65 full-length
protein fusedN-terminally to a SBP and deletion variantsmissing
either the WW domain (Fe65∆WW), the PTB2 (Fe65∆PTB2)
domain or both (Fe65∆WW/PTB2; Figure 4), were subjected
FIGURE 4 | Deletion of the PTB2 domain impairs Fe65 dimerization in cells. (A) HEK293 cells expressing streptavidin-binding peptide (SBP)-myc-Fe65
(SBP-Fe65) and mCherry-Fe65 (mChe-Fe65) as wildtype (wt) or deletion constructs were subjected to pulldown analyses. Total cell lysates (L) and eluates (E) were
analyzed with antibodies against myc, mCherry and GAPDH. (B) Levels of co-precipitated mChe-Fe65 constructs in the eluate are significantly reduced in both
constructs harboring a deletion of the PTB2 domain. (C) Confirmation of similar levels of mChe-Fe65 in the lysate. (D) Similar amounts of SBP-Fe65 are eluted in all
experiments. No GAPDH signal is seen in the eluate (not shown). Mean ± SEM of n = 3 are shown (∗p < 0.05, ∗∗p < 0.01, t-test).
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to streptavidin-based isolation. Indeed, all precipitates of
SBP-tagged Fe65 also recovered mCherry-tagged Fe65 in the
eluate, and thus proving Fe65 dimerization in a cellular context
(Figures 4A,B). Deletion of exclusively the PTB2 domain
resulted in a strong reduction of the interaction with full-length
Fe65 and the samewas true for a Fe65 deletionmutant lacking the
PTB2 and WW domains. In contrast, deletion of solely the WW
domain did not significantly interfere with Fe65 dimerization.
The negative control of the input of SBP- and mCherry-tagged
Fe65 validates the dimerization event (Figures 4C,D). These
results show that Fe65 dimerization takes place in a cellular
environment and implement the PTB2 domain being mainly
responsible for dimer formation.
Furthermore, we tested via Blue Native Gel analyses, if
Fe65 migrates as a dimer. The analyses revealed a single band
with a molecular weight of about 200 kDa pointing indeed to a
full-length Fe65 dimer (Figure 5A). In HEK cells, Fe65 partitions
into a major cytosolic and a minor membrane-bound fraction,
FIGURE 5 | Influence of APP on Fe65 dimerization. HEK cells expressing exogenous Fe65-HA, Fe65-Flag or APP-myc were subjected for subcellular
fractionation. (A) The cytosolic and membrane fractions were separated on a BlueNative-Gel and analyzed by Western Blotting using 3F10 (anti HA) and SC789 (anti
myc) antibodies. Note the shift of Fe65 from the cytosolic to the membrane fraction when co-expressed with APP. (B) Co-Immunoprecipitation (Co-IP) analysis of
whole cell lysates (upper panel) and whole cell lysates and membrane fraction (lower panel) of HEK293 cells expressing Fe65-HA and Fe65-Flag alone or together
with APP-myc. Cells expressing Fe65-HA and APP-myc served as positive and cells lacking Fe65-HA as negative control. For direct load 4% of the total extracts
were loaded. Immunoprecipitation was carried out with anti-HA antibody covered beads. Immunoprecipitates were eluted by denaturation and probes were
subjected for PAGE (8% Tris/glycine gels) and Western analysis using 3F10 (anti HA), SC789 (anti myc) and M2 (anti Flag) antibodies.
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whereas co-expression of APP caused a strong repartitioning
of Fe65 towards the membrane fraction. Co-expression of
APP did not alter electromobility of Fe65 in the native
gel analysis. However, as APP and Fe65 have very similar
molecular weights, the native gel analysis does not allow
for differentiating homotypic from heterotypic complexes. In
the next step we tested, if APP co-expression might affect
Fe65 dimerization. For this purpose, we analyzed HEK293 cells
expressing Flag- and HA-tagged Fe65 and myc-tagged APP
and performed co-immunoprecipitation studies with anti-HA
antibodies from total cell extracts (Figure 5B). For control
we used cells expressing Flag-Fe65 and myc-APP only. The
analyses revealed interactions of HA-Fe65 with both Flag-Fe65
and myc-APP. No clear reduction was observed for HA-
Fe65/Flag-Fe65 interaction upon co-expression with myc-APP.
However, these data again did not allow for differentiating
between a trimeric complex of APP with dimeric Fe65 and
two separate dimeric complexes either consisting of HA-
and Flag-tagged Fe65 or HA-Fe65 and myc-APP. Therefore,
we repeated the Co-IP of Fe65-HA, Fe65-Flag and mycAPP
from HEK293 cell extracts from the membrane fraction.
In this fraction only minor Fe65 amounts are present and
we could not detect any Fe65 dimer. Upon co-expression
of APP, Fe65 was shifted into the membrane fraction as
expected from the known and strong APP-Fe65 interaction
(Radzimanowski et al., 2008c). Interestingly, under these
conditions we succeeded to precipitate the two differently tagged
Fe65 molecules (HA and Flag) and APP (Figure 5B). These
data show that Fe65 at least to some extend can still dimerize
in presence of APP and even a trimeric species might be
formed.
DISCUSSION
Fe65 is a versatile protein-adaptor with an interactome list
of increasing size and complexity. It participates in various
neuronal processes, including neurogenesis, neuronal migration
and positioning, neurite outgrowth, synapse formation and
plasticity, and finally in learning and memory (McLoughlin
and Miller, 2008; Minopoli et al., 2012; Strecker et al., 2016).
The most studied function concerns the gene transactivation
complex together with APP and the histone acetyltransferase
Tip60, although the pathway that at least in parts parallels Notch
signaling and its gene targets are far from being understood
(Cao and Südhof, 2001; Pardossi-Piquard and Checler, 2012).
However, it is possible that in ageing and sporadic Alzheimer’s
disease there is an increase of nuclear signaling concomitant with
amyloidogenic processing of APP and the accumulation of the
Aβ-peptide (Fukumoto et al., 2002; Yang et al., 2003; Goodger
et al., 2009). Inline, it was found that an alternate splice variant
of Fe65 (Fe65a2 isoform) lacking the last exon confers resistance
against very late onset of AD (Hu et al., 2002). The exon codes for
residues starting at the C-terminal end of helix α3 of Fe65-PTB2
and therefore is impaired in AICD binding. Soon after the first
description of the signaling pathway, it was found that complex
formation with APP includes a membrane-associated initiation
process that enables Fe65 to act as transactivator of transcription
once the AICD is cleaved-off (Cao and Südhof, 2004). This
process was associated with an opening of Fe65 by the release
of a WW-PTB2 domain interaction eventually triggered by a
membrane-associated factor.
The AICD/Fe65-PTB2 contact is of hydrophobic character
and recombinant expressed Fe65-PTB2 is aggregation prone
(Radzimanowski et al., 2008a). Here we show by X-ray
crystallography and extended NMR measurements including
spin-labeling PRE techniques that homotypic dimerization of
the Fe65-PTB2 domain mimics AICD binding and effectively
shields the hydrophobic surface. The shielding may reflect the
physiological need of chaperoning this surface in case the binding
partner is not present or binding is to be prevented for functional
reasons. This intermolecular protection does not contradict the
predicted intramolecular WW-PTB2 interaction, which involves
the PTB1-PTB2 boundary and could occur at the same time
inhibiting downstream signaling via the WW-domain (Cao and
Südhof, 2004). Interestingly, the interaction of the Fe65 WW
domain and full length Fe65 is inhibited by excess of AICD,
indicating that AICD binding to the PTB2 domain affects the
interaction of PTB1-PTB2 boundary with the WW domain (Cao
and Südhof, 2004). Homotypic dimerization might also impact
pathological pathways including the AICD/Fe65 interaction.
Of note, the Fe65a2 isoform conferring very late onset AD
resistance (Hu et al., 2002) lacks the dimerization sequence and
thus excludes the self-association. However, all interactions of
Fe65 distinct to the dimerization site and independent of APP
binding are likely to be unaffected by the homotypic Fe65-PTB2
interaction.
We demonstrate by co-immunoprecipitation assays
performed in transfected HEK293 cells in the presence of
Fe65/APP overexpression that at the membrane a Fe65-dimer
complex still co-exists with APP, which could correlate with
the previously described Fe65-activating state of a ‘‘primed
complex’’ (Cao and Südhof, 2004). While there is no indication
yet for an additional membrane-associated protein factor,
activation seems to be guided by the lipid PIP2, which plays
an important role in many endocytic events. PIP2-binding
most likely occurs via the epitope identified by multiple sulfate
ion binding in our dimeric Fe65 crystal structure and/or via
Fe65-PTB1 (Radzimanowski et al., 2008b). As the epitope is in
direct proximity to the dimer interface, membrane association
could also have a direct influence on the monomer-dimer
equilibrium. As also the PTB1-PTB2 linker region is directly
adjacent, the WW-domain is likely be involved in this process
as also indicated by our pull-down assays, which show at least
some influence of the WW-domain on Fe65 dimerization. The
WW-domain recognizes polyproline stretches (Meiyappan et al.,
2007) and might bind to two proline residues close to Fe65-PTB2
and therefore to the PIP2-epitope. Inline, it had been found that
the AICD and the WW-domain cannot bind simultaneously to
the PTB-domains including the linker (Cao and Südhof, 2004).
We therefore propose the following integrated scenario
for Fe65-mediated gene transactivation (Figure 6): Fe65 is
the central adaptor for APP nuclear signaling as validated
earlier. Without its upstream signal, consisting of the AICD
in context of membrane-associated APP, Fe65 resides in a
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FIGURE 6 | Physiological function of Fe65 dimerization. In a schematic model Fe65-mediated APP signaling is divided into four steps: (1) In the cytosol
Fe65 forms a closed dimer by mimicking the AICD and thereby shielding the binding epitope. (2) APP binding at the cell membrane, putatively induced by
phosphatidyl-inositol-4,5-bisphosphate (PIP2)-mediated recruitment, opens the dimer and the AICD/Fe65-PTB2 interaction is formed. The AICD changes from a
disordered to a structured conformation. (3) Upon secretase cleavage of APP, AICD-Fe65 signaling complexes translocate to the nucleus. (4) Respective
transcription activation processes are initiated.
closed conformation. This conformation occurs in the cytosol
and might avoid futile cycles and ensure efficient recycling
of Fe65 pools from the nucleus back to the endomembrane
system or the cell membrane. The closed conformation favors
homotypic dimerization via the structural transition of the
C-terminal helix α3 to strand βct that performs substrate-
mimicry. At the membrane, APP and potentially other protein
and lipid factors like PIP2, induce an opening of Fe65 and the
homodimer finally dissociates. Therefore, membrane association
via the basic cluster and subsequent APP binding would also
result in the opening and activation of Fe65. Similarly, it appears
well feasible that other functions of Fe65, involving interaction
via the WW-domain with Mena or via the PTB1 domain with
other surface receptors such as LRP1 might also go along
with changes in the Fe65 monomer/dimer equilibrium. Further
research will be required to understand these processes in more
detail.
Upon ε-cleavage of APP by γ-secretase, the AICD is released
from themembrane into the cytosol and the Fe65-AICD complex
translocates to the nucleus. Very recent results indicate that the
PTB2 rather than the WW domain is important for the nuclear
localization of Fe65 (Koistinen et al., 2017). Secretase cleavage
is influenced by various aspects like APP cellular localization
(Haass et al., 2012), APP dimerization (Winkler et al., 2015)
and APP and Fe65 phosphorylation (Bukhari et al., 2016).
Due to the tight and extended interaction involving 2/3 of
the AICD (Radzimanowski et al., 2008c) and co-localization
studies (von Rotz et al., 2004), we favor co-migration without
degradation of the AICD. Fe65-PTB1 then binds to Tip60 or
other transcription factors like CP2/LSF/LBP1 (Zambrano et al.,
1998). The WW-domain in the open Fe65 conformation could
finally engage with downstream components as found for the
nucleosome assembly factor SET (Telese et al., 2005) or the AICD
might interact with Med12 from the transcriptional mediator
complex (Xu et al., 2011) essential for starting transcriptional
activation processes.
In summary, our structural and biochemical dissection of
the molecular properties of the multiprotein-adapter Fe65 reveal
the details of an essential regulatory circuit of APP signaling.
The importance of APP signaling in health and disease make it
worth revisiting Fe65 and its different functional conformations
as target for further pharmacological investigations.
ACCESSION NUMBERS
Coordinates and structure factors have been deposited
at the Protein Data Bank (PDB) with accession number
5NQH.
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 May 2017 | Volume 10 | Article 140
Feilen et al. Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
AUTHOR CONTRIBUTIONS
LPF, KH, PS, SP, SE, GS, BS and KW performed the experiments.
All authors analyzed the data and contributed to writing of the
manuscript.
ACKNOWLEDGMENTS
This work was supported by the Deutsche
Forschungsgemeinschaft (FOR1332 to KW and SK), the
Alzheimer Forschung Initiative (to SK), and the Schweizerischer
Nationalfonds (SNF 31003A_146532 to UK). We thank
Jürgen Kopp and Claudia Siegmann from the BZH/Cluster
of Excellence: CellNetworks crystallization platform. We
acknowledge access to the beamlines at the European
Synchrotron Radiation Facility (ESRF) in Grenoble and the
support of the beamline scientists.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://journal.frontiersin.org/article/10.3389/fnmol.2017.00
140/full#supplementary-material
REFERENCES
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W.,
Echols, N., et al. (2010). PHENIX: a comprehensive Python-based system for
macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66,
213–221. doi: 10.1107/S0907444909052925
Ando, K., Iijima, K. I., Elliott, J. I., Kirino, Y., and Suzuki, T. (2001).
Phosphorylation-dependent regulation of the interaction of amyloid precursor
protein with Fe65 affects the production of β-amyloid. J. Biol. Chem. 276,
40353–40361. doi: 10.1074/jbc.M104059200
Baumkotter, F., Schmidt, N., Vargas, C., Schilling, S., Weber, R., Wagner, K., et al.
(2014). Amyloid precursor protein dimerization and synaptogenic function
depend on copper binding to the growth factor-like domain. J. Neurosci. 34,
11159–11172. doi: 10.1523/JNEUROSCI.0180-14.2014
Berlin, K., Longhini, A., Dayie, T. K., and Fushman, D. (2013). Deriving
quantitative dynamics information for proteins and RNAs using ROTDIF with
a graphical user interface. J. Biomol. NMR 57, 333–352. doi: 10.1007/s10858-
013-9791-1
Borg, J. P., Ooi, J., Levy, E., and Margolis, B. (1996). The phosphotyrosine
interaction domains of X11 and FE65 bind to distinct sites on the
YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 6229–6241.
doi: 10.1128/mcb.16.11.6229
Bukhari, H., Kolbe, K., Leonhardt, G., Loosse, C., Schröder, E., Knauer, S., et al.
(2016). Membrane tethering of APP c-terminal fragments is a prerequisite for
T668 phosphorylation preventing nuclear sphere generation. Cell Signal. 28,
1725–1734. doi: 10.1016/j.cellsig.2016.08.007
Cao, X., and Südhof, T. C. (2001). A transcriptionally correction of transcriptively
active complex of APP with Fe65 and histone acetyltransferase Tip60. Science
293, 115–120. doi: 10.1126/science.1058783
Cao, X., and Südhof, T. C. (2004). Dissection of amyloid-β precursor protein-
dependent transcriptional transactivation. J. Biol. Chem. 279, 24601–24611.
doi: 10.1074/jbc.m402248200
Clore, G. M. (2015). Practical aspects of paramagnetic relaxation enhancement in
biological macromolecules.Meth. Enzymol. 564, 485–497. doi: 10.1016/bs.mie.
2015.06.032
Coburger, I., Hoefgen, S., and Than, M. E. (2014). The structural biology of the
amyloid precursor protein APP—a complex puzzle reveals its multi-domain
architecture. Biol. Chem. 395, 485–498. doi: 10.1515/hsz-2013-0280
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995).
NMRPipe: a multidimensional spectral processing system based on UNIX
pipes. J. Biomol. NMR 6, 277–293. doi: 10.1007/bf00197809
Dietl, A., Wild, K., and Simon, B. (2014). 1H, 13C, and 15N chemical shift
assignments of the phosphotyrosine binding domain 2 (PTB2) of human FE65.
Biomol. NMR Assign. 8, 93–95. doi: 10.1007/s12104-013-9460-z
Eggert, S., Midthune, B., Cottrell, B., and Koo, E. H. (2009). Induced dimerization
of the amyloid precursor protein leads to decreased amyloid-β protein
production. J. Biol. Chem. 284, 28943–28952. doi: 10.1074/jbc.M109.038646
Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010). Features and
development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501.
doi: 10.1107/S0907444910007493
Ermekova, K. S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., et al.
(1997). The WW domain of neural protein FE65 interacts with proline-rich
motifs in Mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem.
272, 32869–32877. doi: 10.1074/jbc.272.52.32869
Evans, P. R., and Murshudov, G. N. (2013). How good are my data and
what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214.
doi: 10.1107/S0907444913000061
Fukumoto, H., Cheung, B. S., Hyman, B. T., and Irizarry, M. C. (2002). β-secretase
protein and activity are increased in the neocortex in Alzheimer disease. Arch.
Neurol. 59, 1381–1389. doi: 10.1001/archneur.59.9.1381
Goodger, Z. V., Rajendran, L., Trutzel, A., Kohli, B. M., Nitsch, R. M., and
Konietzko, U. (2009). Nuclear signaling by the APP intracellular domain occurs
predominantly through the amyloidogenic processing pathway. J. Cell Sci. 122,
3703–3714. doi: 10.1242/jcs.048090
Guenette, S., Chang, Y., Hiesberger, T., Richardson, J. A., Eckman, C. B.,
Eckman, E. A., et al. (2006). Essential roles for the FE65 amyloid precursor
protein-interacting proteins in brain development. EMBO J. 25, 420–431.
doi: 10.1038/sj.emboj.7600926
Haass, C., Kaether, C., Thinakaran, G., and Sisodia, S. (2012). Trafficking and
proteolytic processing of APP. Cold Spring Harb. Perspect. Med. 2:a006270.
doi: 10.1101/cshperspect.a006270
Hu, Q., Cool, B. H.,Wang, B., Hearn,M. G., andMartin, G.M. (2002). A candidate
molecular mechanism for the association of an intronic polymorphism of
FE65 with resistance to very late onset dementia of the Alzheimer type. Hum.
Mol. Genet. 11, 465–475. doi: 10.1093/hmg/11.4.465
Johnson, B. A., and Blevins, R. A. (1994). NMR view: a computer program
for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603–614.
doi: 10.1007/BF00404272
Kabsch, W. (2010). XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132.
doi: 10.1107/S0907444909047337
Koistinen, N. A., Edlund, A. K., Menon, P. K., Ivanova, E. V., Bacanu, S.,
Iverfeldt, K., et al. (2017). Nuclear localization of amyloid-β precursor protein-
binding protein Fe65 is dependent on regulated intramembrane proteolysis.
PLoS One 12:e0173888. doi: 10.1371/journal.pone.0173888
Kohli, B. M., Pflieger, D., Mueller, L. N., Carbonetti, G., Aebersold, R.,
Nitsch, R. M., et al. (2012). Interactome of the amyloid precursor protein
APP in brain reveals a protein network involved in synaptic vesicle turnover
and a close association with Synaptotagmin-1. J. Proteome Res. 11, 4075–4090.
doi: 10.1021/pr300123g
Krissinel, E., and Henrick, K. (2007). Inference of macromolecular assemblies
from crystalline state. J. Mol. Biol. 372, 774–797. doi: 10.1016/j.jmb.2007.
05.022
Lichtenthaler, S. F., Haass, C., and Steiner, H. (2011). Regulated intramembrane
proteolysis—lessons from amyloid precursor protein processing. J. Neurochem.
117, 779–796. doi: 10.1111/j.1471-4159.2011.07248.x
McLoughlin, D. M., and Miller, C. C. (2008). The FE65 proteins and Alzheimer’s
disease. J. Neurosci. Res. 86, 744–754. doi: 10.1002/jnr.21532
Meiyappan, M., Birrane, G., and Ladias, J. A. (2007). Structural basis for
polyproline recognition by the FE65 WW domain. J. Mol. Biol. 372, 970–980.
doi: 10.1016/j.jmb.2007.06.064
Frontiers in Molecular Neuroscience | www.frontiersin.org 11 May 2017 | Volume 10 | Article 140
Feilen et al. Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction
Minopoli, G., Gargiulo, A., Parisi, S., and Russo, T. (2012). Fe65 matters: new light
on an old molecule. IUBMB Life 64, 936–942. doi: 10.1002/iub.1094
Müller, T., Meyer, H. E., Egensperger, R., and Marcus, K. (2008). The
amyloid precursor protein intracellular domain (AICD) as modulator of gene
expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s
disease. Prog. Neurobiol. 85, 393–406. doi: 10.1016/j.pneurobio.2008.05.002
Müller, U. C., and Zheng, H. (2012). Physiological functions of APP family
proteins. Cold Spring Harb. Perspect. Med. 2:a006288. doi: 10.1101/cshperspect.
a006288
Pardossi-Piquard, R., and Checler, F. (2012). The physiology of the β-amyloid
precursor protein intracellular domain AICD. J. Neurochem. 120, 109–124.
doi: 10.1111/j.1471-4159.2011.07475.x
Pernot, P., Round, A., Barrett, R., De Maria Antolinos, A., Gobbo, A., Gordon, E.,
et al. (2013). Upgraded ESRF BM29 beamline for SAXS on macromolecules in
solution. J. Synchrotron Radiat. 20, 660–664. doi: 10.1107/S0909049513010431
Petoukhov, M. V., Franke, D., Shkumatov, A. V., Tria, G., Kikhney, A. G.,
Gajda, M., et al. (2012). New developments in the ATSAS program package
for small-angle scattering data analysis. J. Appl. Crystallogr. 45, 342–350.
doi: 10.1107/S0021889812007662
Radzimanowski, J., Beyreuther, K., Sinning, I., and Wild, K. (2008a).
Overproduction, purification, crystallization and preliminary X-ray analysis of
human Fe65-PTB2 in complex with the amyloid precursor protein intracellular
domain. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64, 409–412.
doi: 10.1107/S1744309108009524
Radzimanowski, J., Ravaud, S., Schlesinger, S., Koch, J., Beyreuther, K., Sinning, I.,
et al. (2008b). Crystal structure of the human Fe65-PTB1 domain. J. Biol. Chem.
283, 23113–23120. doi: 10.1074/jbc.M800861200
Radzimanowski, J., Simon, B., Sattler, M., Beyreuther, K., Sinning, I., and Wild, K.
(2008c). Structure of the intracellular domain of the amyloid precursor protein
in complex with Fe65-PTB2. EMBO Rep. 9, 1134–1140. doi: 10.1038/embor.
2008.188
Ramelot, T. A., Gentile, L. N., and Nicholson, L. K. (2000). Transient structure
of the amyloid precursor protein cytoplasmic tail indicates preordering
of structure for binding to cytosolic factors. Biochemistry 39, 2714–2725.
doi: 10.1021/bi992580m
Russo, T., Faraonio, R., Minopoli, G., De Candia, P., De Renzis, S., and
Zambrano, N. (1998). Fe65 and the protein network centered around the
cytosolic domain of the Alzheimer’s β-amyloid precursor protein. FEBS Lett.
434, 1–7. doi: 10.1016/s0014-5793(98)00941-7
Selkoe, D. J., and Hardy, J. (2016). The amyloid hypothesis of Alzheimer’s disease
at 25 years. EMBOMol. Med. 8, 595–608. doi: 10.15252/emmm.201606210
Shen, Y., and Bax, A. (2010). SPARTA+: amodest improvement in empirical NMR
chemical shift prediction by means of an artificial neural network. J. Biomol.
NMR 48, 13–22. doi: 10.1007/s10858-010-9433-9
Shen, Y., Delaglio, F., Cornilescu, G., and Bax, A. (2009). TALOS+: a hybrid
method for predicting protein backbone torsion angles from NMR chemical
shifts. J. Biomol. NMR 44, 213–223. doi: 10.1007/s10858-009-9333-z
Simon, B., Madl, T., Mackereth, C. D., Nilges, M., and Sattler, M. (2010). An
efficient protocol for NMR-spectroscopy-based structure determination of
protein complexes in solution. Angew. Chem. Int. Ed Engl. 49, 1967–1970.
doi: 10.1002/anie.200906147
Strecker, P., Ludewig, S., Rust, M., Mundinger, T. A., Görlich, A., Krächan, E. G.,
et al. (2016). FE65 and FE65L1 share common synaptic functions and
genetically interact with the APP family in neuromuscular junction formation.
Sci. Rep. 6:25652. doi: 10.1038/srep25652
Telese, F., Bruni, P., Donizetti, A., Gianni, D., D’Ambrosio, C., Scaloni, A.,
et al. (2005). Transcription regulation by the adaptor protein Fe65 and the
nucleosome assembly factor SET. EMBO Rep. 6, 77–82. doi: 10.1038/sj.embor.
7400309
Uhlik, M. T., Temple, B., Bencharit, S., Kimple, A. J., Siderovski, D. P., and
Johnson, G. L. (2005). Structural and evolutionary division of phosphotyrosine
binding (PTB) domains. J. Mol. Biol. 345, 1–20. doi: 10.1016/j.jmb.2004.
10.038
von Rotz, R. C., Kohli, B. M., Bosset, J., Meier, M., Suzuki, T., Nitsch, R. M., et al.
(2004). The APP intracellular domain forms nuclear multiprotein complexes
and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435–4448.
doi: 10.1242/jcs.01323
Winkler, E., Julius, A., Steiner, H., and Langosch, D. (2015). Homodimerization
protects the amyloid precursor protein C99 fragment from cleavage by
γ-secretase. Biochemistry 54, 6149–6152. doi: 10.1021/acs.biochem.5b00986
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R.,
et al. (2011). Overview of the CCP4 suite and current developments. Acta
Crystallogr. D Biol. Crystallogr. 67, 235–242. doi: 10.1107/S0907444910045749
Xu, X., Zhou, H., and Boyer, T. G. (2011). Mediator is a transducer of amyloid-
precursor-protein-dependent nuclear signalling. EMBO Rep. 12, 216–222.
doi: 10.1038/embor.2010.210
Yang, Z., Cool, B. H., Martin, G. M., and Hu, Q. (2006). A dominant role for FE65
(APBB1) in nuclear signaling. J. Biol. Chem. 281, 4207–4214. doi: 10.1074/jbc.
m508445200
Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. L., et al. (2003).
Elevated β-secretase expression and enzymatic activity detected in sporadic
Alzheimer disease. Nat. Med. 9, 3–4. doi: 10.1038/nm0103-3
Zambrano, N., Bimonte, M., Arbucci, S., Gianni, D., Russo, T., and Bazzicalupo, P.
(2002). feh-1 and apl-1, the Caenorhabditis elegans orthologues of mammalian
Fe65 and β-amyloid precursor protein genes, are involved in the same pathway
that controls nematode pharyngeal pumping. J. Cell Sci. 115, 1411–1422.
Zambrano, N., Minopoli, G., de Candia, P., and Russo, T. (1998). The Fe65 adaptor
protein interacts through its PID1 domain with the transcription factor
CP2/LSF/LBP1. J. Biol. Chem. 273, 20128–20133. doi: 10.1074/jbc.273.32.
20128
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Feilen, Haubrich, Strecker, Probst, Eggert, Stier, Sinning,
Konietzko, Kins, Simon and Wild. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 12 May 2017 | Volume 10 | Article 140
